Register
Login:
Share:
Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'


Ideagen Broker Ratings



Broker Ratings for Ideagen (IDEA)


Share Price: 89.50Bid: 89.00Ask: 90.00Change: -0.50 (-0.56%)Faller - Ideagen
Spread: 1.00Spread as %: 1.12%Open: 90.00High: 90.50Low: 89.50Yesterday’s Close: 90.00


Broker Recommendations for Ideagen (IDEA)
DateBrokerRatingOld TargetNew TargetChange
07-Nov-17FinnCapcorporate-108.00Reiteration
24-Jan-17FinnCapcorporate-78.00Reiteration
07-Nov-16FinnCapcorporate-69.00Reiteration
13-Oct-16FinnCapcorporate-69.00Reiteration
08-Aug-16FinnCapcorporate65.0069.00Reiteration
19-Jul-16FinnCapcorporate61.0065.00Reiteration
18-May-16FinnCapcorporate52.0061.00Reiteration
29-Apr-16FinnCapcorporate--Reiteration
31-Mar-16FinnCapcorporate-52.00Reiteration
18-Mar-16FinnCapcorporate-52.00Reiteration
19-Nov-15FinnCapcorporate--Reiteration
23-Sep-15FinnCapcorporate--Reiteration


Registered members see more Ideagen broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.